Conference
Quality of life (QOL) outcomes with cediranib/placebo in combination with carboplatin/paclitaxel (CP) in advanced non-small cell lung cancer (ANSCLC): results from NCIC CTG BR.24
Authors
Lee CW; Ding K; Le Maitre A; Han L; Laurie SA; Goss G; Shepherd FA; Arnold A; Frymire E; Seymour L
Volume
4
Pagination
pp. S288-S288
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
September 1, 2009
Conference proceedings
JOURNAL OF THORACIC ONCOLOGY
Issue
9
ISSN
1556-0864